Evaluation of albumin-binding PD-L1-targeted VHH for PET imaging in colorectal cancer
American Journal of Nuclear Medicine and Molecular Imaging · 2026 · 16 (3) · 131-142
DOI: 10.62347/gbvo2400 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Rui Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, Shanxi Medical University Taiyuan, Shanxi, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, School of Public Health, Shanxi Medical University Taiyuan, Shanxi, China.
- Department of Nuclear Medicine, Peking University Shenzhen Hospital Shenzhen, Guangdong, China.
- Department of Pharmacy, Peking University Shenzhen Hospital Shenzhen, Guangdong, China.
Zitieren
APA
Zhang, R., Li, J., Chen, P., Dong, M., & Ding, L. (2026). Evaluation of albumin-binding PD-L1-targeted VHH for PET imaging in colorectal cancer. American Journal of Nuclear Medicine and Molecular Imaging, 16(3), 131-142. https://doi.org/10.62347/gbvo2400
Vancouver
Zhang R, Li J, Chen P, Dong M, Ding L. Evaluation of albumin-binding PD-L1-targeted VHH for PET imaging in colorectal cancer. American Journal of Nuclear Medicine and Molecular Imaging. 2026;16(3):131-142. doi:10.62347/gbvo2400
BibTeX
@article{Zhang2026,
author = {Zhang, Rui and Li, Jun and Chen, Ping and Dong, Mengjie and Ding, Ling},
title = {Evaluation of albumin-binding PD-L1-targeted VHH for PET imaging in colorectal cancer},
journal = {American Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {16},
number = {3},
pages = {131--142},
doi = {10.62347/gbvo2400}
}
EUVIMED